TVTX Travere Therapeutics, Inc.
Healthcare$44.29-0.32%ClosedMarket Cap: $4.12B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$51.50
Target (Median)
$51.50
Target Range
$49.00 - $54.00
Upside from current price: 16.3%
Rating Distribution
2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-05 | Citigroup | maintain | Buy | Buy |
| 2026-05-05 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-05 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-05 | TD Cowen | maintain | Buy | Buy |
| 2026-04-24 | Guggenheim | maintain | Buy | Buy |
| 2026-04-14 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-25 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-06 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-11-28 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $2.57 | $974.8M | 8 |
| Sun Dec 31 | $3.46 | $1.18B | 5 |
| Mon Dec 31 | $4.46 | $1.45B | 1 |
| Tue Dec 31 | $5.55 | $1.69B | 1 |